Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Full Editions
BIOCENTURY
BIOCENTURY INNOVATIONS
BIOCENTURY EXTRA
BIOCENTURY WEEK IN REVIEW
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
Future Leaders
NewsMakers
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
search
Previous
article
Back
to Feed
Next
article
Share
Text Size
A
A
A
Print
BioMed X, Roche parter to treat immune-mediated diseases
By Shannon Lehnbeuter | Mar 16, 2018 | 4:55 PM GMT
BioMed X GmbH (Heidelberg, Germany) and Roche (SIX:ROG; OTCQX:RHHBY) partnered to develop
Read the full
120
word article
User Sign In
Previous
article
Back
to Feed
Next
article
JavaScript is necessary to work with this application.